The estimated Net Worth of Ventures Iv, L.P.5 Am Partn... is at least $25 Million dollars as of 16 May 2019. Ventures Partn owns over 615,000 units of Homology Medicines Inc stock worth over $205,935 and over the last 7 years Ventures sold FIXX stock worth over $24,827,163.
Ventures has made over 4 trades of the Homology Medicines Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Ventures sold 615,000 units of FIXX stock worth $13,204,050 on 16 May 2019.
The largest trade Ventures's ever made was selling 615,000 units of Homology Medicines Inc stock on 16 May 2019 worth over $13,204,050. On average, Ventures trades about 237,231 units every 36 days since 2018. As of 16 May 2019 Ventures still owns at least 221,435 units of Homology Medicines Inc stock.
You can see the complete history of Ventures Partn stock trades at the bottom of the page.
Over the last 7 years, insiders at Homology Medicines Inc have traded over $108,214,465 worth of Homology Medicines Inc stock and bought 3,033,333 units worth $51,999,993 . The most active insiders traders include Steven Gillis, James Edeerfield Management..., and Kush Parmar. On average, Homology Medicines Inc executives and independent directors trade stock every 26 days with the average trade being worth of $106,785. The most recent stock trade was executed by Paul Alloway on 25 March 2024, trading 23,530 units of FIXX stock currently worth $21,883.
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Homology Medicines Inc executives and other stock owners filed with the SEC include: